Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Marrow Allografts after Nonmyeloablative Conditioning: Effect of Cell Dose on Rejection and Degree of Donor Chimerism.

Razvan Diaconescu, MD, Wendy Leisenring, ScD, Christoph Kahl, MD, Mohamed Sorror, MD, Eustacia Zellmer, Michael Maris, MD, Marie-Terese Little, PhD, Rainer Storb, MD

Blood (2004) 104 (11): 1202.

https://doi.org/10.1182/blood.V104.11.1202.1202

Published: 2004

Journal Articles

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

Frederic Baron, Michael Maris, Barry Storer, Brenda Sandmaier, Jens Panse, Thomas Chauncey, Mohamed Sorror, Marie Terese Little, David Maloney, Rainer Storb, Shelly Heimfeld

Blood (2004) 104 (11): 2753.

https://doi.org/10.1182/blood.V104.11.2753.2753

Published: 2004

Journal Articles

Conversion of Low Donor Chimerism Following Nonmyeloablative Conditioning for Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusion (DLI).

Brenda M. Sandmaier, David G. Maloney, Michael B. Maris, Thomas R. Chauncey, Michael Pulsipher, Wolfgang Bethge, Marie-Terese Little, Rainer Storb

Blood (2004) 104 (11): 186.

https://doi.org/10.1182/blood.V104.11.186.186

Published: 2004

Journal Articles

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Dietger Niederwieser, Michael Maris, Judith A. Shizuru, Effie Petersdorf, Ute Hegenbart, Brenda M. Sandmaier, David G. Maloney, Barry Storer, Thoralf Lange, Thomas Chauncey, Michael Deininger, Wolfram Pönisch, Claudio Anasetti, Ann Woolfrey, Marie-Terese Little, Karl G. Blume, Peter A. McSweeney, Rainer F. Storb

Blood (2003) 101 (4): 1620–1629.

https://doi.org/10.1182/blood-2002-05-1340

Published: 2003

Journal Articles

Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model

Kristina L. Rhoades, Christopher J. Hetherington, Nari Harakawa, Donald A. Yergeau, Liming Zhou, Li-Qin Liu, Marie-Terese Little, Daniel G. Tenen, Dong-Er Zhang

Blood (2000) 96 (6): 2108–2115.

https://doi.org/10.1182/blood.V96.6.2108

Published: 2000

NARROW

Marrow Allografts after Nonmyeloablative Conditioning: Effect of Cell Dose on Rejection and Degree of Donor Chimerism.

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

Conversion of Low Donor Chimerism Following Nonmyeloablative Conditioning for Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusion (DLI).

Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model

Email alerts

ASH Publications

American Society of Hematology

Marrow Allografts after Nonmyeloablative Conditioning: Effect of Cell Dose on Rejection and Degree of Donor Chimerism.

Higher Doses of Transplanted CD34+, CD3+ and CD8+ Cells Are Associated with Better Donor T-Cell Chimerism and Less Graft Rejection, but Not with GVHD after Nonmyeloablative Conditioning for Unrelated Hematopoietic Cell Transplantation.

Conversion of Low Donor Chimerism Following Nonmyeloablative Conditioning for Hematopoietic Cell Transplantation (HCT) Using Pentostatin and Donor Lymphocyte Infusion (DLI).

Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only